Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Altman Z2-Score: 9.60 (As of Jul. 05, 2026) — Near Median


XKLS:7178 Y.S.P. Southeast Asia Holding Bhd XKLS:7178
82 GF Score
Price RM2.02
GF Value RM2.40
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Y.S.P. Southeast Asia Holding Bhd Altman Z2-Score?

Y.S.P. Southeast Asia Holding Bhd XKLS:7178 -0.98% 82 Altman Z2-Score is 9.60 as of Jul. 05, 2026, which is 8% above its 10-year median of 8.86. GuruFocus rates XKLS:7178 with a GF Score™ of 82/100 and a GF Value™ of RM2.40 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 994 Drug Manufacturers companies, Y.S.P. Southeast Asia Holding Bhd ranks better than 84.31% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Y.S.P. Southeast Asia Holding Bhd has a Altman Z2-Score of 9.60, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score or its related term are showing as below:

XKLS:7178' s Altman Z2-Score Range Over the Past 10 Years
Min: 7.47   Med: 8.86   Max: 10.08
Current: 9.6

During the past 13 years, Y.S.P. Southeast Asia Holding Bhd's highest Altman Z2-Score was 10.08. The lowest was 7.47. And the median was 8.86.


Y.S.P. Southeast Asia Holding Bhd  (XKLS:7178) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Y.S.P. Southeast Asia Holding Bhd Altman Z2-Score Related Terms


Y.S.P. Southeast Asia Holding Bhd Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Y.S.P. Southeast Asia Holding Bhd Altman Z2-Score Chart

Y.S.P. Southeast Asia Holding Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.14 9.96 9.28 9.52 9.49

Y.S.P. Southeast Asia Holding Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.50 8.70 9.59 9.49 9.60

XKLS:7178 vs ZTS, UTHR, VTRS: Altman Z2-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Y.S.P. Southeast Asia Holding Bhd Altman Z2-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score falls into.


XKLS:7178
82GF Score
Y.S.P. Southeast Asia Holding Bhd XKLS:7178
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Y.S.P. Southeast Asia Holding Bhd Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.5641+3.26*0.4752+6.72*0.0689+1.05*3.6994
=9.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was RM552.0 Mil.
Total Current Assets was RM381.6 Mil.
Total Current Liabilities was RM70.3 Mil.
Retained Earnings was RM262.3 Mil.
Pre-Tax Income was 13.927 + 10.159 + 8.934 + 2.356 = RM35.4 Mil.
Interest Expense was -0.663 + -0.639 + -0.694 + -0.671 = RM-2.7 Mil.
Total Liabilities was RM115.7 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(381.645 - 70.297)/551.964
=0.5641

X2=Retained Earnings/Total Assets
=262.293/551.964
=0.4752

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(35.376 - -2.667)/551.964
=0.0689

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(428.097 - 0)/115.722
=3.6994

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Y.S.P. Southeast Asia Holding Bhd has a Altman Z2-Score of 9.60 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 9.60 mean?
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a Altman Z2-Score of 9.60 as of Jul. 05, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. This is near median its historical median of 8.86. Over the past decade, Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score has ranged from 7.47 to 10.08. According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #156 out of 994 companies in the Drug Manufacturers industry, placing it in the top 15.7%.
Is Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score too high?
Y.S.P. Southeast Asia Holding Bhd's current Altman Z2-Score of 9.60 is near median its 10-year median of 8.86. Over the past 10 years, this metric has ranged from a low of 7.47 to a high of 10.08. The Drug Manufacturers industry median Altman Z2-Score is 3.88. Y.S.P. Southeast Asia Holding Bhd's value of 9.60 is 147.7% above this industry median. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #156 out of 994 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's Altman Z2-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #156 out of 994 companies for Altman Z2-Score. This places Y.S.P. Southeast Asia Holding Bhd in the top 16% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 3.88. Y.S.P. Southeast Asia Holding Bhd's value of 9.60 is 147.7% above this benchmark. Historically, Y.S.P. Southeast Asia Holding Bhd's own Altman Z2-Score has ranged from 7.47 to 10.08 over the past decade. While the company's 10-year median is 8.86 vs. the industry median of 3.88, Y.S.P. Southeast Asia Holding Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Drug Manufacturers company?
The median Altman Z2-Score among Drug Manufacturers companies is 3.88, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current Altman Z2-Score of 9.60 is 147.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. For the Drug Manufacturers industry, the median Altman Z2-Score is 3.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current Altman Z2-Score is 9.60, which is near median its own 10-year median of 8.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.40, compared to a current price of RM2.02 — trading 15.8% below its estimated fair value. The current Altman Z2-Score is 9.60, which is near median its 10-year median of 8.86 and 147.7% above the Drug Manufacturers industry median of 3.88. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current Altman Z2-Score is 9.60 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?

Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued. The current stock price of RM2.02 is trading 15.8% below its estimated GF Value™ of RM2.40. GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:7178:

  • Altman Z2-Score: 9.60 (near median its 10-year median of 8.86)
  • GF Value™: RM2.40 vs. price of RM2.02 (15.8% below fair value)
  • GF Score™: 82/100 with 3 warning signs
  • Industry Position: 147.7% above the Drug Manufacturers median (#156 of 994)

No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Y.S.P. Southeast Asia Holding Bhd Business Description

Address Number 1, Jalan Wan Kadir, Level 22, Menara LGB, Taman Tun Dr. Ismail, Kuala Lumpur, MYS, 60000
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
82GF Score

Get the complete analysis for XKLS:7178

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.02
Price
RM2.40
GF Value